$0.6270
-0.0227-3.49%
Last update: Oct 26, 8:32 AM
Aldeyra Therapeutics Inc (ALDX) Stock Price, Quote, News & History
ALDXNASDAQ
Aldeyra stock plunges after FDA rejects its dry eye drug reproxalap, raising concerns over efficacy and future growth prospects.
You can purchase shares of Aldeyra Therapeutics (NASDAQ:ALDX) through any online brokerage.
Other companies in Aldeyra Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Aldeyra Therapeutics has a consensus price target of $7.00.
The stock price for Aldeyra Therapeutics (NASDAQ: ALDX) is $0.627 last updated October 26, 2026 at 8:32 AM EDT.
There are no upcoming dividends for Aldeyra Therapeutics.
Aldeyra Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Aldeyra Therapeutics.
Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a...
